Y-Intercept (HK)’s Citius Pharmaceuticals CTXR Stock Holding History

Y-Intercept (HK)’s Portfolio CTXR Stock Details CTXR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$227K	Buy
2023 Q2	–	Sell
2023 Q1	$12.4K	Buy
2022 Q3	–	Sell
2022 Q2	$16K	Buy